Latest News

EVA Pharma Launches the First Egyptian Generic for Type 2 Diabetes Treatment Diaflozimet® Tablets

Read More ›

EVA Pharma starts export of COVID-19 Antiviral Avipiravir® Worldwide

Read More ›

FDA Broadens Emergency Use Authorization for Remdesivir to Include All Hospitalized Patients for Treatment of COVID-19

Read More ›

Two Egyptian-Manufactured Medicines are Soon Entering Europe and Canada

Read More ›

EVA Pharma Talent Academy Equips 3 Thousands Pharmacy Students for the Job Market

Read More ›

EVA Pharma Releases 500 Thousand Packs of the Analgesic and Antipyretic Drug Paracetamol under the Trade Name Stopadol®

Read More ›

The Supreme Committee for Viruses Recognizes EVA Pharma as a Partner in the Eradication of Virus C in Egypt

Read More ›

EVA Pharma Explores the Manufacturing of COVID-19 Vaccines with European and American Companies

Read More ›

The Telegraph announced that “Sofosbuvir” and “Daclatasvir” Produced by EVA Pharma are reducing Coronavirus Death Rate

Read More ›

EVA Pharma launches the first Egyptian medication for Chronic Obstructive Pulmonary Disease

Read More ›

EVA Pharma Granted License to Manufacture and Distribute “Remdesivir” in 127 countries

Read More ›